116 related articles for article (PubMed ID: 3281016)
1. Modification of risk factors for coronary heart disease. Five-year results of a school-based intervention trial.
Walter HJ; Hofman A; Vaughan RD; Wynder EL
N Engl J Med; 1988 Apr; 318(17):1093-100. PubMed ID: 3281016
[TBL] [Abstract][Full Text] [Related]
2. Coronary heart disease prevention in childhood: one-year results of a randomized intervention study.
Walter HJ; Hofman A; Connelly PA; Barrett LT; Kost KL
Am J Prev Med; 1986; 2(4):239-45. PubMed ID: 3453186
[TBL] [Abstract][Full Text] [Related]
3. Serum cholesterol in young men and subsequent cardiovascular disease.
Klag MJ; Ford DE; Mead LA; He J; Whelton PK; Liang KY; Levine DM
N Engl J Med; 1993 Feb; 328(5):313-8. PubMed ID: 8419817
[TBL] [Abstract][Full Text] [Related]
4. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.
Pekkanen J; Linn S; Heiss G; Suchindran CM; Leon A; Rifkind BM; Tyroler HA
N Engl J Med; 1990 Jun; 322(24):1700-7. PubMed ID: 2342536
[TBL] [Abstract][Full Text] [Related]
5. Trends in serum cholesterol levels from 1980 to 1987. The Minnesota Heart Survey.
Burke GL; Sprafka JM; Folsom AR; Hahn LP; Luepker RV; Blackburn H
N Engl J Med; 1991 Apr; 324(14):941-6. PubMed ID: 2002818
[TBL] [Abstract][Full Text] [Related]
6. Normal fasting plasma glucose levels and type 2 diabetes in young men.
Tirosh A; Shai I; Tekes-Manova D; Israeli E; Pereg D; Shochat T; Kochba I; Rudich A;
N Engl J Med; 2005 Oct; 353(14):1454-62. PubMed ID: 16207847
[TBL] [Abstract][Full Text] [Related]
7. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the effects of soy protein intake on serum lipids.
Anderson JW; Johnstone BM; Cook-Newell ME
N Engl J Med; 1995 Aug; 333(5):276-82. PubMed ID: 7596371
[TBL] [Abstract][Full Text] [Related]
9. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects.
Mensink RP; Katan MB
N Engl J Med; 1990 Aug; 323(7):439-45. PubMed ID: 2374566
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure.
Swain JF; Rouse IL; Curley CB; Sacks FM
N Engl J Med; 1990 Jan; 322(3):147-52. PubMed ID: 2152973
[TBL] [Abstract][Full Text] [Related]
12. Trends in coronary heart disease risk factors in Auckland 1982-94.
Jackson R; Yee RL; Priest P; Shaw L; Beaglehole R
N Z Med J; 1995 Nov; 108(1011):451-4. PubMed ID: 8538961
[TBL] [Abstract][Full Text] [Related]
13. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
Vestfold Heartcare Study Group
Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
[TBL] [Abstract][Full Text] [Related]
14. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
[TBL] [Abstract][Full Text] [Related]
15. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
[TBL] [Abstract][Full Text] [Related]
16. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.
Stefanick ML; Mackey S; Sheehan M; Ellsworth N; Haskell WL; Wood PD
N Engl J Med; 1998 Jul; 339(1):12-20. PubMed ID: 9647874
[TBL] [Abstract][Full Text] [Related]
17. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study.
Sytkowski PA; Kannel WB; D'Agostino RB
N Engl J Med; 1990 Jun; 322(23):1635-41. PubMed ID: 2288563
[TBL] [Abstract][Full Text] [Related]
18. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
[TBL] [Abstract][Full Text] [Related]
19. Healthy Start: a comprehensive health education program for preschool children.
Williams CL; Squillace MM; Bollella MC; Brotanek J; Campanaro L; D'Agostino C; Pfau J; Sprance L; Strobino BA; Spark A; Boccio L
Prev Med; 1998; 27(2):216-23. PubMed ID: 9578999
[TBL] [Abstract][Full Text] [Related]
20. Action Schools! BC: a school-based physical activity intervention designed to decrease cardiovascular disease risk factors in children.
Reed KE; Warburton DE; Macdonald HM; Naylor PJ; McKay HA
Prev Med; 2008 Jun; 46(6):525-31. PubMed ID: 18377970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
